Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.097 | 0.8 |
mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | -0.017 | 0.8 |
mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.0097 | 0.8 |